First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes.
about
First trimester screening using ultrasound and serum markers in Panamanians: Factors associated with adverse pregnancy outcomes.Relationships between cell-free DNA and serum analytes in the first and second trimesters of pregnancy.Maternal estriol concentrations in early gestation predict infant telomere lengthMaternal Serum Screening Markers and Adverse Outcome: A New PerspectiveMaternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers.Management of abnormal serum markers in the absence of aneuploidy or neural tube defectsMid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcomeAbnormal analyte preeclampsia: do the second-trimester maternal serum analytes help differentiate preeclampsia subtypes?Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells.Predictive value of pregnancy-associated plasma protein-A (PAPP-A) and free beta-hCG on fetal growth restriction: results of a prospective study.Low PAPP-A: the impact of ultrasound to evaluate fetal growth.Second-Trimester 3-Dimensional Placental Sonography as a Predictor of Small-for-Gestational-Age Birth Weight.Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing.Introduction of a nomogram for predicting adverse pregnancy outcomes based on maternal serum markers in the quad screen test.Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.Increased false positive Down syndrome screening in women with sickle cell anemia.Placental hyperinflation and the risk of adverse perinatal outcome.Biochemical screening for aneuploidy in patients with donor oocyte pregnancies compared with autologous pregnancies.Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta.Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial.Pregnancy-Associated Plasma Protein A Levels in Late First Trimester Pregnancies with Small-for-Gestational Age Neonates: A Prospective Case-Control Study.Recurrence of extreme serum analytes in consecutive pregnancies and association with obstetrical outcomes.Two-dimensional sonographic assessment of maximum placental length and thickness in the second trimester: a reproducibility study.Uterine torsion and subsequent rupture in a gravid bicornuate uterus associated with an elevated alpha-fetoprotein.Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction
P2860
Q33977342-E671DAA7-8CC0-446A-BD07-33D7C75CD6B0Q34287182-7554885F-28D8-448C-A86A-F48ABD6D3BF1Q34810905-C8053FDB-0ABF-42BC-B288-5A1E51EB93F9Q35667145-695E2D43-6417-4308-B7F0-10C57DC6DD6CQ36439778-4A510A79-D6B8-4666-9E6A-5694B82D5024Q36901631-4E6654B7-5369-4A95-9775-416669F0CCE7Q36939466-8D35ACAA-1548-44B3-A6F6-563D43DC13A2Q36957465-AA7E6BAA-8BFA-4B43-86CE-A8C59F78A4F6Q37141917-DBC081A1-8FB1-4EFE-BF35-9B6D15D32A65Q38943748-D63BD21A-29AC-4A84-8FD3-37436F7C1BBDQ40332146-F01D0B93-F684-491F-9F30-7BF9428B8F7AQ40340576-776500D4-E731-41F3-870D-AAD32C213818Q40686334-098381C4-1F80-4B39-B717-AC3827974112Q40966521-78AA8DC5-C1A5-4CE8-B092-CCD521182523Q41216987-82CE04E1-1231-498A-9C4F-47560CF4B31DQ41363097-BDB31D53-1D5B-4041-9691-A3DD4600AABBQ41743018-12F4B9B6-F8E0-4F67-8C37-EE7C46D269CCQ43504346-8150EBE3-8E5A-4686-8CB5-EF871E8A9DD5Q46537104-DA69541F-E344-409B-932B-9795E13AB3A1Q48114217-357CE960-087E-49A1-AAD7-F43EF7A922FBQ50623216-4EF8C1B3-FCEE-47B6-BDAF-2CAFA5A27739Q50891866-0968A193-563A-4BC6-87D9-AD7302F61142Q53097616-AD4553D2-C89E-47DF-AB04-760C206327F1Q53157848-C6702612-3475-4A59-B184-044DF7D8A17AQ55240514-62C2B8DA-AFB6-4480-A382-EFD555102C71Q57212283-8CEEAF42-4CA9-4EE0-A1E0-71A610D08A72
P2860
First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@en
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@nl
type
label
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@en
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@nl
prefLabel
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@en
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@nl
P1476
First- and second-trimester ma ...... nd adverse obstetric outcomes.
@en
P2093
Lorraine Dugoff
Society for Maternal-Fetal Medicine
P304
P356
10.1097/AOG.0B013E3181DA93DA
P407
P577
2010-05-01T00:00:00Z